Benson, Kathryn R. K.
Diamantidis, Clarissa J.
Davenport, Clemontina A.
Sandler, Robert S.
Boulware, L. Ebony
Mohottige, Dinushika https://orcid.org/0000-0001-5099-4910
Funding for this research was provided by:
National Institutes for Health (P30DK034987, R01 CA66635)
NIMHD (U54MD012530 Duke Center for Research to Advance Healthcare Equity (REACH Equity))
Mario Family Foundation
School of Medicine, Duke University (Eugene A. Stead Student Research Scholarship)
NIH Clinical and Translational Science Award (UL1TR002553)
Article History
Received: 23 March 2023
Revised: 29 July 2023
Accepted: 2 August 2023
First Online: 18 August 2023
Declarations
:
: The datasets generated and analyzed during the current study were collected as above during the years 1996–2000 as part of a parent study, at which time informed consent was obtained from all individual participants. The Duke University IRB approved the use of this study for these analyses as exempt, under the study number Pro00052724.
: Dr. Clarissa Diamantidis reports consultancy with Optum Labs. Kathryn Benson, Dr. Dinushika Mohottige, Dr. Clemontina Davenport, Dr. L. Ebony Boulware, and Dr. Robert Sandler have no financial interests.